DNACF Dena Co., Ltd. Forecast, Technical & Fundamental Analysis

DNACF's Stochastic Oscillator is staying in oversold zone for 16 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Momentum Indicator moved above the 0 level on October 07, 2025. You may want to consider a long position or call options on DNACF as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DNACF just turned positive on October 01, 2025. Looking at past instances where DNACF's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

DNACF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.930) is normal, around the industry mean (10.801). P/E Ratio (10.340) is within average values for comparable stocks, (36.930). DNACF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.367). Dividend Yield (0.015) settles around the average of (0.034) among similar stocks. P/S Ratio (1.525) is also within normal values, averaging (3.083).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DNACF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DNACF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock worse than average.